Stock Analysis on Net
Stock Analysis on Net

AmerisourceBergen Corp. (NYSE:ABC)

$22.49

This company has been moved to the archive! The financial data has not been updated since August 2, 2023.

Return on Equity (ROE)
since 2005

Microsoft Excel

Paying user area

Try for free

AmerisourceBergen Corp. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

AmerisourceBergen Corp., ROE, long-term trends, calculation

Microsoft Excel
ROE = 100 × Net income (loss) attributable to AmerisourceBergen Corporation1 ÷ Total AmerisourceBergen Corporation stockholders’ equity (deficit)1
Sep 30, 2022 = 100 × ÷
Sep 30, 2021 = 100 × ÷
Sep 30, 2020 = 100 × ÷
Sep 30, 2019 = 100 × ÷
Sep 30, 2018 = 100 × ÷
Sep 30, 2017 = 100 × ÷
Sep 30, 2016 = 100 × ÷
Sep 30, 2015 = 100 × ÷
Sep 30, 2014 = 100 × ÷
Sep 30, 2013 = 100 × ÷
Sep 30, 2012 = 100 × ÷
Sep 30, 2011 = 100 × ÷
Sep 30, 2010 = 100 × ÷
Sep 30, 2009 = 100 × ÷
Sep 30, 2008 = 100 × ÷
Sep 30, 2007 = 100 × ÷
Sep 30, 2006 = 100 × ÷
Sep 30, 2005 = 100 × ÷

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30), 10-K (reporting date: 2015-09-30), 10-K (reporting date: 2014-09-30), 10-K (reporting date: 2013-09-30), 10-K (reporting date: 2012-09-30), 10-K (reporting date: 2011-09-30), 10-K (reporting date: 2010-09-30), 10-K (reporting date: 2009-09-30), 10-K (reporting date: 2008-09-30), 10-K (reporting date: 2007-09-30), 10-K (reporting date: 2006-09-30), 10-K (reporting date: 2005-09-30).

1 US$ in thousands

Net Income Trends
The net income attributable to the corporation exhibits notable volatility over the analyzed period. Starting at approximately 265 million in 2005, it generally increased, peaking around 718 million in 2012. A significant decline occurred in 2015, resulting in a net loss of about 135 million, followed by a strong recovery in 2016 with net income surpassing 1.4 billion. The company reached another peak of around 1.66 billion in 2018, but faced a sharp downturn in 2020, posting a substantial loss of approximately 3.4 billion. The subsequent years showed a rebound to positive net income levels, with values around 1.5 billion in 2021 and 1.7 billion in 2022.
Stockholders’ Equity Patterns
Total stockholders’ equity generally declined from 4.28 billion in 2005 to about 1.96 billion in 2014, indicating a weakening equity base during this interval. A further steep decline is observed in 2015, with equity dropping to 633 million, but recovery followed, restoring equity to near 2.9 billion by 2018. However, a significant turnaround takes place in 2020, where equity turns negative, at approximately -1 billion, followed by a slight improvement in 2021 and 2022 but remaining in deficit territory. This suggests episodes of financial distress or substantial value erosion during the later years.
Return on Equity (ROE) Analysis
ROE shows a general upward trend from 6.18% in 2005 to a peak exceeding 29% in 2012, reflecting increasing profitability relative to equity in this period. After a drop in 2014 to 14.13%, there is a dramatic negative ROE in 2015 (-21.29%), coinciding with the reported net loss and equity decline. A remarkable rebound occurs in 2016, leaping to 67.06%, and further climbing to 56.55% in 2018. Data for 2020 shows an anomalous and very high ROE figure exceeding 689%, primarily due to the negative equity base, which distorts the ratio. Overall, the ROE exhibits high volatility, corresponding with fluctuations in net income and equity values.
Summary of Financial Stability
Financial performance over the reviewed period is marked by considerable fluctuation, highlighting phases of both strong profitability and severe setbacks. The sharp losses around 2015 and 2020, alongside periods of negative or minimal equity, suggest financial instability at times. Recovery phases indicate resilience but also ongoing exposure to volatility. The company’s profitability relative to equity, as measured by ROE, confirms these dynamics with wide swings reflecting the underlying net income and equity changes.

Comparison to Competitors

AmerisourceBergen Corp., ROE, long-term trends, comparison to competitors

Microsoft Excel
AmerisourceBergen Corp. Abbott Laboratories Elevance Health Inc. Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc.
Sep 30, 2022
Sep 30, 2021
Sep 30, 2020
Sep 30, 2019
Sep 30, 2018
Sep 30, 2017
Sep 30, 2016
Sep 30, 2015
Sep 30, 2014
Sep 30, 2013
Sep 30, 2012
Sep 30, 2011
Sep 30, 2010
Sep 30, 2009
Sep 30, 2008
Sep 30, 2007
Sep 30, 2006
Sep 30, 2005

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30), 10-K (reporting date: 2015-09-30), 10-K (reporting date: 2014-09-30), 10-K (reporting date: 2013-09-30), 10-K (reporting date: 2012-09-30), 10-K (reporting date: 2011-09-30), 10-K (reporting date: 2010-09-30), 10-K (reporting date: 2009-09-30), 10-K (reporting date: 2008-09-30), 10-K (reporting date: 2007-09-30), 10-K (reporting date: 2006-09-30), 10-K (reporting date: 2005-09-30).

Comparison to Sector (Health Care Equipment & Services)

AmerisourceBergen Corp., ROE, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel
AmerisourceBergen Corp. Health Care Equipment & Services
Sep 30, 2022
Sep 30, 2021
Sep 30, 2020
Sep 30, 2019
Sep 30, 2018
Sep 30, 2017
Sep 30, 2016
Sep 30, 2015
Sep 30, 2014
Sep 30, 2013
Sep 30, 2012
Sep 30, 2011
Sep 30, 2010
Sep 30, 2009
Sep 30, 2008
Sep 30, 2007
Sep 30, 2006
Sep 30, 2005

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30), 10-K (reporting date: 2015-09-30), 10-K (reporting date: 2014-09-30), 10-K (reporting date: 2013-09-30), 10-K (reporting date: 2012-09-30), 10-K (reporting date: 2011-09-30), 10-K (reporting date: 2010-09-30), 10-K (reporting date: 2009-09-30), 10-K (reporting date: 2008-09-30), 10-K (reporting date: 2007-09-30), 10-K (reporting date: 2006-09-30), 10-K (reporting date: 2005-09-30).

Comparison to Industry (Health Care)

AmerisourceBergen Corp., ROE, long-term trends, comparison to industry (health care)

Microsoft Excel
AmerisourceBergen Corp. Health Care
Sep 30, 2022
Sep 30, 2021
Sep 30, 2020
Sep 30, 2019
Sep 30, 2018
Sep 30, 2017
Sep 30, 2016
Sep 30, 2015
Sep 30, 2014
Sep 30, 2013
Sep 30, 2012
Sep 30, 2011
Sep 30, 2010
Sep 30, 2009
Sep 30, 2008
Sep 30, 2007
Sep 30, 2006
Sep 30, 2005

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30), 10-K (reporting date: 2015-09-30), 10-K (reporting date: 2014-09-30), 10-K (reporting date: 2013-09-30), 10-K (reporting date: 2012-09-30), 10-K (reporting date: 2011-09-30), 10-K (reporting date: 2010-09-30), 10-K (reporting date: 2009-09-30), 10-K (reporting date: 2008-09-30), 10-K (reporting date: 2007-09-30), 10-K (reporting date: 2006-09-30), 10-K (reporting date: 2005-09-30).